secwatch.observer — SEC 8-K summary
======================================

Issuer:     Cryoport, Inc. (CYRX)
CIK:        0001124524
Form:       8-K
Filed at:   2022-02-09T23:59:59+00:00
Accession:  0001104659-22-017128
Event type: other
Sentiment:  neutral
Materiality: 0.65
Item codes: 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Cryoport expects MVE New Prague production resumption Feb 14; $4-5M Q1 revenue impact
--------------------------------------------------------------------------------

- Fire on Jan 25 at MVE Biological Solutions' New Prague facility halted production.
- Production expected to resume week of Feb 14, 2022; full production ramp during Q1.
- Revenue impact of $4-5 million limited to Q1 2022.
- Insurance expected to cover majority of restoration costs and business interruption.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1124524/000110465922017128/0001104659-22-017128-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1124524/000110465922017128/tm226004d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-22-017128

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer